C is for Vitamin C—a key ingredient for immune cell function
Harnessing the combined power of Vitamin C and TET proteins may give scientists a leg up in treating autoimmune diseases
Preparing T cells for the long haul
New LJI research could keep cancer-fighting T cells from burning out before the job is done
Sydney Ramirez investigates a lingering COVID-19 question
New A.P. Giannini Foundation Fellowship opens the door to an in-depth look at SARS-CoV-2 infections
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
A biochemist takes on Lassa virus
LJI Postdoctoral Fellow Adrian Enriquez wins funding to study how antibodies fight the deadly Lassa virus.
Hard-working enzyme keeps immune cells in line
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Many cancer patients may need a sequential one-two punch of immunotherapies
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
Sonia Sharma zeros in on metabolites
Cancer immunotherapies may have a better chance of working if scientists can reintroduce a missing metabolite
When a scientist picks up a camera
Dawid Zyla explores the world’s hidden patterns
Timothy Baffi receives ACS award to study acute myeloid leukemia
New support from the American Cancer Society fuels research into the primary mutations behind many cancer types